Impressive project, much needed. I have read the whitepaper, very long and detailed (a bit hard to understand, though). You think you will have a good share of predicted $60 Billion market for genomic technologies in 2020?
We think that we can claim a large part of the market, because our platform will be an infrastructure for the market.
Is it possible that your share of the market will be related to the value of the tokens? I think this is important question and prospective investors would like to know that before taking part in ICO.